SCHEMBL23640331

SCHEMBL23640331

Cc1ccc(OCCNS(C)(=O)=O)cc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
HTT P42858 4/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
PKM P14618 3/20 0.54
DRD2 P14416 1/20 0.54
DRD4 P21917 1/20 0.54
DRD3 P35462 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.51
HPGD P15428 2/20 0.48
MAPK1 P28482 1/20 0.48
ROCK2 O75116 2/20 0.47
MAP4K4 O95819 2/20 0.47
PIM1 P11309 2/20 0.47
PRKACA P17612 2/20 0.47
CDK2 P24941 2/20 0.47
GSK3B P49841 2/20 0.47
HIPK2 Q9H2X6 2/20 0.47
MAPT P10636 2/20 0.47
DYRK3 O43781 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10191940 0.81 ALDH1A1 (0.65) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL15262441 0.81 ALDH1A1 (0.50) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL10336962 0.78 ALDH1A1 (0.69) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL5075726 0.78 DRD2 (0.61) ALDH1A1HTTMEN1KMT2ADRD2
SCHEMBL9934132 0.77 ALDH1A1 (0.49) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL27931162 0.77 PDIA6 (0.53) ALDH1A1HTTMEN1KMT2ADRD2
SCHEMBL14410510 0.77 DRD2 (0.61) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL3763682 0.76 DRD2 (0.58) ALDH1A1HTTMEN1KMT2ADRD2
SCHEMBL18291308 0.76 ALDH1A1 (0.55) ALDH1A1HTTMEN1KMT2APKM
SCHEMBL9142888 0.76 MEN1 (0.79) ALDH1A1HTTMEN1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119376-A1 TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2022-04-21 US disclosed
EP-3848367-A1 TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119376-A1 TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS CRBN, CSNK2A1, CSNK2A2 ALDH1A1 4087/4885HTT 1232/4885MEN1 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.